BLAIR FERGUSON: Open Payments
NPI 1033771787 · FORT LAUDERDALE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$719 in 29 payments from 14 companies in 2025. Trend: 2023 $1,194 · 2024 $669 · 2025 $719
Food & beverage: $719
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $223 |
| Lilly USA, LLC | 3 | $66 |
| GENZYME CORPORATION | 2 | $65 |
| Regeneron Healthcare Solutions, Inc. | 2 | $62 |
| ABBVIE INC. | 2 | $53 |
| REVANCE THERAPEUTICS, INC. | 1 | $45 |
| PFIZER INC. | 2 | $44 |
| E.R. Squibb & Sons, L.L.C. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Amgen Inc. | 1 | $28 |
Products named: TREMFYA, DUPIXENT, RINVOQ, DAXXIFY, CIBINQO, Sotyktu, EBGLYSS, OTEZLA.
Industry payments across FL — which companies pay providers there.
